Dr. Jeffrey Bradstreet’s Family Breaks Silence
I am honored that the Bradstreet family sat down to talk with me about the beloved late MD, Jeffrey Bradstreet.
I didn’t know how they felt when I wrote the first story about his tragic death when he was found in a river, with a gunshot wound to his chest, 7 weeks ago. Shortly thereafter, more holistic doctors were found dead, mostly here in Florida and mostly holistic, some of whom we knew well. I wrote the stories, as tough as it was, and we’re still waiting for answers.
I’ve been fortunate to talk with the Bradstreets for a while now, and they are nothing but an honest, sincere caring family, and I cannot imagine how they must feel. I cannot even begin to understand the depth of their pain. I am just honored that they trust me and opened up to me for this first interview ever. Here we talk about Dr. Bradstreet and the man they knew as Jeff. We also discuss GcMAF and many other topics. Please click on the Youtube video above to listen.
This is Erin Elizabeth on Wednesday August 12, 2015.
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages
Dario Siniscalco123*, James Jeffrey Bradstreet45, Alessandra Cirillo6 and Nicola Antonucci7
Journal of Neuroinflammation 2014, 11:78 doi:10.1186/1742-2094-11-78
Bradstreet JJ, Vogelaar E, Thyer L: Initial observations of elevated alpha-N-acetylgalactosaminidase activity associated with autism and observed reductions from Gcprotein-Macrophage Activating Factor injections. Autism Insights 2012, 4:31-38. (The link is on this page: http://www.la-press.com/journal-autism-insights-j155 ).
Siniscalco D, Cirillo A, Bradstreet JJ, Antonucci N: Epigenetic findings in autism: new perspectives for therapy.
Int J Environ Res Public Health 2013, 10(9):4261-4273.
http://link.springer.com/article/10.1007%2Fs10803-013-1824-9
Siniscalco D, Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, Fasano A, Bradstreet JJ, Maione S, Antonucci N: Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.
J Autism Dev Disord 2013, 43(11):2686-2695.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892177/
Bradstreet, J. J., Pacini, S., & Ruggiero, M. (2013). A New Methodology of Viewing Extra-Axial Fluid and Cortical Abnormalities in Children with Autism via Transcranial Ultrasonography. Frontiers in Human Neuroscience, 7, 934. doi:10.3389/fnhum.2013.00934
Siniscalco D, Bradstreet JJ, Sych N, Antonucci N. Perspectives on the Use of Stem Cells for Autism Treatment. Stem Cells Int. 2013 Oct: 262438. doi: 10.1155/2013/262438
www.ncbi.nlm.nih.gov/pmc/articles/PMC3810518/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999775/
Siniscalco, D., Bradstreet, J. J., Sych, N., & Antonucci, N. (2014). Mesenchymal stem cells in treating autism: Novel insights. World Journal of Stem Cells, 6(2), 173–178. doi:10.4252/wjsc.v6.i2.173
http://journal.frontiersin.org/article/10.3389/fimmu.2013.00140/abstract
Siniscalco D, Bradstreet JJ, Antonucci N: Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation.
Front Immunol 2013, 4:140.
http://link.springer.com/article/10.1007%2Fs10803-013-1824-9
Siniscalco D, Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, Fasano A, Bradstreet JJ, Maione S, Antonucci N: Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.
J Autism Dev Disord 2013, 43(11):2686-2695.
